Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection. (10th June 2021) - Bachelard, A; Isernia, V; Vallois, D; Le Gac, S; Chalal, L; Landman, R; Damond, F; Descamps, D; Yazdanpanah, Y; Peytavin, G; Ghosn, J